Aytu Biopharma (AYTU) EBIT Margin Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) EBIT Margin Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,382.00 |
| Sep 30, 2025 | 1,548.00 |
| Jun 30, 2025 | -572.00 |
| Mar 31, 2025 | 7,189.00 |
| Dec 31, 2024 | 14,599.00 |
| Sep 30, 2024 | 32,328.00 |
| Jun 30, 2024 | 25,136.00 |
| Mar 31, 2024 | 16,940.00 |
| Dec 31, 2023 | 27,030.00 |
| Sep 30, 2023 | 23,380.00 |
| Jun 30, 2023 | 41,418.00 |
| Mar 31, 2023 | 120,103.00 |
| Dec 31, 2022 | 35,382.00 |
| Sep 30, 2022 | 39,816.00 |
| Jun 30, 2022 | 54,844.00 |
| Mar 31, 2022 | 32,312.00 |
| Dec 31, 2021 | 47,985.00 |
| Sep 30, 2021 | 72,833.00 |
| Jun 30, 2021 | 131,645.00 |
| Dec 31, 2020 | 60,554.00 |